Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombocytopenia 4 Lymphoma, Non-Hodgkin 4 Multiple Myeloma 3 Hodgkin Disease 2 Solid Tumor 1 Sarcoma, Ewing 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Hematologic Neoplasms 1 Glioblastoma 1 Chemotherapy-induced Thrombocytopenia 1

Interventions

Carboplatin 156 Paclitaxel 154 Bevacizumab 96 Cyclophosphamide 61 Gemcitabine 46 olaparib 45 Cisplatin 45 Topotecan 44 niraparib 40 liposomal doxorubicin 40 pembrolizumab 38 Surveys and Questionnaires 33 Filgrastim 31 Hyperthermic Intraperitoneal Chemotherapy 29 Docetaxel 27 Taxes 25 Blood Specimen Collection 24 fludarabine 23 Drug Therapy 23 Cytoreduction Surgical Procedures 23 Peripheral Blood Stem Cell Transplantation 21 Etoposide 21 Doxorubicin 21 Magnetic Resonance Spectroscopy 20 durvalumab 17 Specimen Handling 17 Albumin-Bound Paclitaxel 17 Immunoglobulin G 15 Disulfides 15 Letrozole 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Neoplasms × romiplostim × Clear all

NCT03622931 2021-02-08

TRACEII

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡